Robert O. Webster

3.7k total citations
86 papers, 3.1k citations indexed

About

Robert O. Webster is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Robert O. Webster has authored 86 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 33 papers in Immunology and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Robert O. Webster's work include S100 Proteins and Annexins (14 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (13 papers) and Complement system in diseases (10 papers). Robert O. Webster is often cited by papers focused on S100 Proteins and Annexins (14 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (13 papers) and Complement system in diseases (10 papers). Robert O. Webster collaborates with scholars based in United States, United Kingdom and Russia. Robert O. Webster's co-authors include Peter M. Henson, Richard R. Kew, Thomas M. Hyers, Rita M. Heuertz, Gary L. Larsen, Richard B. Johnston, Ira M. Goldstein, Alpha A. Fowler, Craig A. Piquette and Alan H. Stephenson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Robert O. Webster

86 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert O. Webster United States 35 1.0k 757 752 486 356 86 3.1k
Robin G. Kunkel United States 22 910 0.9× 550 0.7× 635 0.8× 321 0.7× 323 0.9× 29 2.7k
K J Johnson United States 34 1.9k 1.9× 1.2k 1.6× 793 1.1× 328 0.7× 446 1.3× 63 4.5k
P R Craddock United States 15 1.1k 1.0× 566 0.7× 736 1.0× 526 1.1× 319 0.9× 17 3.6k
Frederick N. Miller United States 30 579 0.6× 520 0.7× 483 0.6× 182 0.4× 450 1.3× 109 2.8k
Luciano Ottonello Italy 32 1.4k 1.4× 835 1.1× 264 0.4× 293 0.6× 303 0.9× 101 3.3k
Yukitaka Ueki Japan 33 990 1.0× 640 0.8× 233 0.3× 504 1.0× 336 0.9× 160 3.5k
Joseph J. Boyle United Kingdom 36 1.4k 1.3× 1.3k 1.7× 333 0.4× 587 1.2× 310 0.9× 66 3.4k
Bradford S. Schwartz United States 20 513 0.5× 917 1.2× 494 0.7× 266 0.5× 301 0.8× 50 3.1k
Timothy H. Pohlman United States 32 1.1k 1.1× 933 1.2× 346 0.5× 348 0.7× 251 0.7× 64 3.5k
Naoto Yamaguchi Japan 31 604 0.6× 976 1.3× 329 0.4× 226 0.5× 285 0.8× 105 2.5k

Countries citing papers authored by Robert O. Webster

Since Specialization
Citations

This map shows the geographic impact of Robert O. Webster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert O. Webster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert O. Webster more than expected).

Fields of papers citing papers by Robert O. Webster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert O. Webster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert O. Webster. The network helps show where Robert O. Webster may publish in the future.

Co-authorship network of co-authors of Robert O. Webster

This figure shows the co-authorship network connecting the top 25 collaborators of Robert O. Webster. A scholar is included among the top collaborators of Robert O. Webster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert O. Webster. Robert O. Webster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chabot, J, Jatin Narula, Mahua Roy, et al.. (2021). A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs. SHILAP Revista de lepidopterología. 1. 731340–731340. 4 indexed citations
2.
Fidock, Mark, Carl Laxton, Peter Colman, et al.. (2011). The Innate Immune Response, Clinical Outcomes, and Ex Vivo HCV Antiviral Efficacy of a TLR7 Agonist (PF-4878691). Clinical Pharmacology & Therapeutics. 89(6). 821–829. 64 indexed citations
3.
4.
Nedderman, Angus N. R., et al.. (2006). Pharmacokinetics and metabolism of UK-383,367 in rats and dogs: A rationale for long-lived plasma radioactivity. Xenobiotica. 36(5). 399–418. 13 indexed citations
5.
Webster, Robert O., et al.. (2006). Pharmacokinetics and clearance processes of UK-279,276 (rNIF) in rat and dog: Comparison with human data. Xenobiotica. 36(4). 341–349. 5 indexed citations
6.
Heuertz, Rita M., et al.. (2004). Native and modified C-reactive protein bind different receptors on human neutrophils. The International Journal of Biochemistry & Cell Biology. 37(2). 320–335. 64 indexed citations
7.
Webster, Robert O., J.B. Phipps, Ruth Hyland, & Don K. Walker. (2003). Evaluation of the role of the asialoglycoprotein receptor in the clearance of UK-279,276 (recombinant neutrophil inhibitory factor). Xenobiotica. 33(9). 945–956. 5 indexed citations
8.
Dahms, Thomas E., et al.. (2003). C‐reactive protein increases F‐actin assembly and cortical distribution with resultant loss of lamellipod formation in human neutrophils. Cell Biology International. 28(1). 33–39. 11 indexed citations
9.
Mulshine, James L., et al.. (2000). Considerations in developing successful, population‐based molecular screening and prevention of lung cancer. Cancer. 89(S11). 2465–2467. 2 indexed citations
10.
Heuertz, Rita M., Sally M. Tricomi, Uthayashanker Ezekiel, & Robert O. Webster. (1999). C-reactive Protein Inhibits Chemotactic Peptide-induced p38 Mitogen-activated Protein Kinase Activity and Human Neutrophil Movement. Journal of Biological Chemistry. 274(25). 17968–17974. 77 indexed citations
11.
Keller, Cesar A., et al.. (1997). Increased Gelatinolytic Activity in Bronchoalveolar Lavage Fluid in Stable Lung Transplant Recipients. American Journal of Respiratory and Critical Care Medicine. 156(6). 1978–1986. 21 indexed citations
12.
Heuertz, Rita M. & Robert O. Webster. (1997). Role of C-reactive protein in acute lung injury. Molecular Medicine Today. 3(12). 539–545. 23 indexed citations
13.
Ahmed, Nahed K., et al.. (1996). Transgenic Mice Expressing Rabbit C-Reactive Protein Exhibit Diminished Chemotactic Factor-Induced Alveolitis. American Journal of Respiratory and Critical Care Medicine. 153(3). 1141–1147. 46 indexed citations
14.
Flick, Michael R., Robert O. Webster, J. M. Hoeffel, et al.. (1993). Effect of phenytoin on acute lung injuries in unanesthetized sheep. Critical Care Medicine. 21(10). 1563–1571. 1 indexed citations
15.
Burkey, Thomas H. & Robert O. Webster. (1993). Adenosine inhibits fMLP-stimulated adherence and superoxide anion generation by human neutrophils at an early step in signal transduction. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1175(3). 312–318. 27 indexed citations
16.
Kew, Richard R., et al.. (1992). Ceruloplasmin and Transferrin Levels Are Altered in Serum and Bronchoalveolar Lavage Fluid of Patients with the Adult Respiratory Distress Syndrome. American Review of Respiratory Disease. 145(5). 1009–1015. 32 indexed citations
17.
Farmer, Joseph C., Thomas H. Burkey, Richard R. Kew, & Robert O. Webster. (1991). Concentration-dependent Regulatory Effects of Prostaglandin E 1 on Human Neutrophil function In Vitro. American Review of Respiratory Disease. 144(3_pt_1). 593–599. 13 indexed citations
18.
Webster, Robert O., et al.. (1990). Ceruloplasmin inhibits endothelial cell injury and hydroxyl radical production by phorbol myristate acetate (PMA)-stimulated neutrophils. 1 indexed citations
19.
Ohar, Jill, et al.. (1990). A Rabbit Model of Pulmonary Hypertension Induced by the Synthetic Platelet-activating Factor Acetylglyceryl Ether Phosphorylcholine. American Review of Respiratory Disease. 141(1). 104–110. 19 indexed citations
20.
Stephenson, Alan H., Andrew J. Lonigro, Thomas M. Hyers, Robert O. Webster, & Alpha A. Fowler. (1988). Increased Concentrations of Leukotrienes in Bronchoalveolar Lavage Fluid of Patients with ARDS or At Risk for ARDS. American Review of Respiratory Disease. 138(3). 714–719. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026